tiprankstipranks
Purple Biotech (PPBT)
NASDAQ:PPBT
US Market
PPBT
Purple Biotech
RESEARCH TOOLSreports
Want to see PPBT full AI Analyst Report?

Purple Biotech (PPBT) Stock News & Sentiment

1,151 Followers
Purple Biotech Q1 2026 Results Highlight CAPTN-3 Pivot and IM1240 Preclinical Momentum
Premium
Company Announcements
Purple Biotech Q1 2026 Results Highlight CAPTN-3 Pivot and IM1240 Preclinical Momentum
6d ago
6K
PPBT
Purple Biotech Unveils Promising IM1240 Preclinical Data From CAPTN-3 Immunotherapy Platform
Premium
Company Announcements
Purple Biotech Unveils Promising IM1240 Preclinical Data From CAPTN-3 Immunotherapy Platform
24d ago
6K
PPBT
Purple Biotech Forms Scientific Advisory Board to Drive CAPTN-3 Tri-Specific Antibody Platform
Premium
Company Announcements
Purple Biotech Forms Scientific Advisory Board to Drive CAPTN-3 Tri-Specific Antibody Platform
28d ago
6K
PPBT
Purple Biotech Taps Converge Bio’s AI to Turbocharge Tri-Specific Antibody Platform
Premium
Company Announcements
Purple Biotech Taps Converge Bio’s AI to Turbocharge Tri-Specific Antibody Platform
2M ago
6K
PPBT
Purple Biotech Is Building What Could Be the Next Generation of Cancer Immunotherapy (NASDAQ: PPBT)
Premium
TipRanks Newswire
Purple Biotech Is Building What Could Be the Next Generation of Cancer Immunotherapy (NASDAQ: PPBT)
2M ago
CODX
PPBT
Patent Cliff Risk: How Expiring Protections Threaten Purple Biotech’s Future Exclusivity and Returns
Premium
Company Announcements
Patent Cliff Risk: How Expiring Protections Threaten Purple Biotech’s Future Exclusivity and Returns
2M ago
PPBT
Purple Biotech Updates March 2026 Corporate Outlook and Pipeline Milestones
Premium
Company Announcements
Purple Biotech Updates March 2026 Corporate Outlook and Pipeline Milestones
2M ago
6K
PPBT
More PPBT News >

PPBT News on the Web

Analysts Are Bullish on These Healthcare Stocks: Purple Biotech (PPBT), Satellos Bioscience (MSLE)
TipRanks News
Neutral
Purple Biotech Q1 2026 Results Highlight CAPTN-3 Pivot and IM1240 Preclinical Momentum
TipRanks News
Bearish
Purple Biotech Unveils Promising IM1240 Preclinical Data From CAPTN-3 Immunotherapy Platform
TipRanks News
Neutral
Purple Biotech reports IM1240 demonstrates potent anti-tumor activity
TipRanks News
Bullish
Purple Biotech Forms Scientific Advisory Board to Drive CAPTN-3 Tri-Specific Antibody Platform
TipRanks News
Bearish
Purple Biotech Taps Converge Bio’s AI to Turbocharge Tri-Specific Antibody Platform
TipRanks News
Bearish
Purple Biotech announces collaboration with Converge Bio
TipRanks News
Bullish
Purple Biotech Is Building What Could Be the Next Generation of Cancer Immunotherapy (NASDAQ: PPBT)
TipRanks News
Bullish

News Score - Last 7 Days

Very Negative
PPBT
Sector Average
Media Buzz
This Week3 articles
Weekly Average0.75 articles
News Sentiment
This Week0%
Sector Average77%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PPBT’s Media Buzz Sentiment?
3 articles about PPBT were published this week. In an average week, 0.75 articles are published.
    What is PPBT’s weekly average amount of articles?
    In an average week, 0.75 articles about PPBT are published.
      What is PPBT’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      GOSSGossamer Bio
      RLAYRelay Therapeutics
      IMVTImmunovant
      ROIVRoivant Sciences
      PROKProKidney
      Showing the stocks with the most bullish news sentiment over the past week